Acurx - Recent events include - Ibeza Phase 2b results published in Lancet Microbe - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176330178 $12 mil line of credit established - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176271933 $2.67 mil proceeds from exercise of warrants (but a complicated transaction) - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176338374 De-listing and reverse split saga - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176271854 SEC filing - June 20, 2025 -- complicated warrants transaction(s) - https://www.sec.gov/ix?doc=/Archives/edgar/data/0001736243/000110465925060902/tm2518285d1_8k.htm ---